Cargando…
Amyloid imaging in the differential diagnosis of dementia: review and potential clinical applications
In the past decade, positron emission tomography (PET) with carbon-11-labeled Pittsburgh Compound B (PIB) has revolutionized the neuroimaging of aging and dementia by enabling in vivo detection of amyloid plaques, a core pathologic feature of Alzheimer's disease (AD). Studies suggest that PIB-P...
Autores principales: | Laforce, Robert, Rabinovici, Gil D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308020/ https://www.ncbi.nlm.nih.gov/pubmed/22071129 http://dx.doi.org/10.1186/alzrt93 |
Ejemplares similares
-
Amyloid Imaging in Aging and Dementia: Testing the Amyloid Hypothesis In Vivo
por: Rabinovici, G. D., et al.
Publicado: (2009) -
Clinical applications of neuroimaging in patients with Alzheimer's disease: a review from the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012
por: Soucy, Jean-Paul, et al.
Publicado: (2013) -
Amyloid imaging for differential diagnosis of dementia: incremental value compared to clinical diagnosis and [(18)F]FDG PET
por: Hellwig, Sabine, et al.
Publicado: (2018) -
Critical review of the Appropriate Use Criteria for amyloid imaging: Effect on diagnosis and patient care
por: Apostolova, Liana G., et al.
Publicado: (2016) -
Beta-amyloid imaging in dementia
por: Chun, Kyung Ah
Publicado: (2018)